Analysts Expect Modest 2012 Contribution from HPV Assay for Gen-Probe | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment analysts have weighed in on the US Food and Drug Administration's clearance of Gen-Probe's Aptima HPV assay, saying that they expect a modest revenue contribution in 2012 but a potentially significant ramp in sales over the following two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.